Adult height and prevalence of coronary artery calcium: the National Heart, Lung, and Blood Institute Family Heart Study.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3970195)

Published in Circ Cardiovasc Imaging on December 11, 2013

Authors

Michael D Miedema1, Andrew B Petrone, Donna K Arnett, John A Dodson, J Jeffrey Carr, James S Pankow, Steven C Hunt, Michael A Province, Aldi Kraja, J Michael Gaziano, Luc Djousse

Author Affiliations

1: Brigham and Women's Hospital, Division of Aging, and Boston Veteran Affairs Healthcare System, Harvard Medical School, Boston, MA.

Articles cited by this

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology (2005) 11.29

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29

Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation (1995) 5.90

Leg and trunk length at 43 years in relation to childhood health, diet and family circumstances; evidence from the 1946 national birth cohort. Int J Epidemiol (2002) 3.98

Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67

NHLBI Family Heart Study: objectives and design. Am J Epidemiol (1996) 3.21

Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging (2009) 2.86

Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland. Am J Epidemiol (2002) 2.52

Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J (2009) 1.85

Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation (1994) 1.85

Association between height and coronary heart disease mortality: a prospective study of 35,000 twin pairs. Am J Epidemiol (2006) 1.85

Socio-economic position and coronary heart disease risk factors in children and young people. Evidence from UK epidemiological studies. Eur J Public Health (2002) 1.67

Height and incidence of cardiovascular disease in male physicians. Circulation (1993) 1.62

Negative relationships between growth in height and levels of cholesterol in puberty: a 3-year follow-up study. Int J Epidemiol (2003) 1.61

Adult height and cause-specific mortality: a large prospective study of South Korean men. Am J Epidemiol (2003) 1.50

Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31,199 middle-aged men and women in Finland. Am J Epidemiol (2000) 1.48

Short stature, lung function and risk of a heart attack. Int J Epidemiol (1989) 1.33

Adult height, stroke, and coronary heart disease. Am J Epidemiol (1998) 1.24

Height loss in older men: associations with total mortality and incidence of cardiovascular disease. Arch Intern Med (2006) 1.21

Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health (2005) 1.18

Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure. J Hypertens (2003) 1.10

Adult height and the risk of cardiovascular disease among middle aged men and women in Japan. Eur J Epidemiol (2010) 1.09

Short stature and risk of mortality and cardiovascular disease: negative findings from the NHANES I epidemiologic follow-up study. J Am Coll Cardiol (1996) 1.06

Cardiology patient page. Use of new imaging techniques to screen for coronary artery disease. Circulation (2003) 1.03

Height, lung function, and mortality from cardiovascular disease among the elderly. Am J Epidemiol (1994) 1.01

Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2011) 0.94

Alcohol and coronary artery calcium prevalence, incidence, and progression: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2008) 0.93

The role of body position and gravity in the symptoms and treatment of various medical diseases. Swiss Med Wkly (2004) 0.92

Childhood socio-economic position and risk of coronary heart disease in middle age: a study of 49,321 male conscripts. Eur J Public Health (2010) 0.89

Height and risk of heart failure in the Physicians' Health Study. Am J Cardiol (2012) 0.80

Adult height and risk of coronary heart disease: Tehran Lipid and Glucose Study. J Epidemiol (2012) 0.77

Articles by these authors

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2011) 11.02

Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03

Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70

Mixed linear model approach adapted for genome-wide association studies. Nat Genet (2010) 8.47

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33

Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation (2006) 7.16

Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34

Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20

Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA (2008) 5.92

C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75

A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet (2007) 5.64

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43

Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA (2007) 4.60

Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes (2008) 4.20

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care (2005) 3.96

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92

New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62

Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol (2004) 3.53

Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation (2009) 3.50

Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2007) 3.48

The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst (2008) 3.40

Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation (2009) 3.37

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37

A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32

Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA (2004) 3.31

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet (2010) 3.24

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18

Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol (2008) 3.16

Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med (2002) 3.12

The Genetic Analysis Workshop 16 Problem 3: simulation of heritable longitudinal cardiovascular phenotypes based on actual genome-wide single-nucleotide polymorphisms in the Framingham Heart Study. BMC Proc (2009) 3.11

Health benefits of gastric bypass surgery after 6 years. JAMA (2012) 3.10

Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility--MESA study. Radiology (2005) 3.08

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst (2002) 3.03

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99

Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J Am Coll Cardiol (2006) 2.94

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2007) 2.92

Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res (2011) 2.92

Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90

Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA (2009) 2.90

Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc (2010) 2.88

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Avoiding the high Bonferroni penalty in genome-wide association studies. Genet Epidemiol (2010) 2.79

Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78

A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev (2007) 2.77

FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77